How did the COVID-19 pandemic affect antibiotic consumption within humanitarian emergencies? Results from five humanitarian contexts

被引:2
作者
Yavuz, Tuba [1 ]
Clezy, Kate
Skender, Kristina [2 ]
Goldberg, Jacob [2 ]
Vallieres, Frederique [3 ]
机构
[1] Trinity Coll Dublin, Trinity Ctr Global Hlth, Dublin, Ireland
[2] Operat Ctr Amsterdam OCA, Medecins Sans Frontieres, Amsterdam, Netherlands
[3] Trinity Coll Dublin, Sch Psychol, Dublin, Ireland
关键词
Antibiotic consumption; Time-series analysis; Humanitarian settings; COVID-19; MIDDLE-INCOME COUNTRIES; ANTIMICROBIAL RESISTANCE; STEWARDSHIP; ACCESS;
D O I
10.1016/j.infpip.2024.100385
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Both high- and low-income countries reported increased antibiotic consumption among COVID-19 patients during the first months of the pandemic. To date, however, no studies have examined changes in antibiotic consumption during the COVID-19 pandemic within humanitarian emergency contexts. Method: Data was collected by Me<acute accent>decins Sans Frontie`res (MSF) for the years 2018e2021 across the following humanitarian settings: Afghanistan (Lashkar Gah), Bangladesh (Kutupalong), the Democratic Republic of Congo (Mweso and Baraka), and South Sudan (Bentiu). Inpatient and outpatient antibiotic consumption was calculated as Daily Defined Dose (DDD) per 1000 inhabitants per day, as per the World Health Organisation's (WHO) Collaborating Centre for Drug Statistics Methodology. Interrupted time series (ITS) analysis, using an autoregressive integrated moving average (ARIMA) model was used to analyse retrospective monthly antibiotic consumption. The impact of COVID-19 pandemic was evaluated as total antibiotic consumption and according to WHO Access, Watch, Reserve (AWaRe) group classifications within each humanitarian setting. Results: The COVID-19 pandemic had no statistically significant impact on total antibiotic consumption in South Sudan (Bentiu) and Bangladesh (Kutupalong). Similarly, the pandemic had no impact on total antibiotic consumption in DR Congo (Baraka), despite an initial 0.27% (estimate=.274, p-value=0.006) increase in March 2020 driven by Access group antibiotics. Meanwhile, total antibiotic consumption in DR Congo (Mweso) and Afghanistan (Lashkar Gah) declined by 0.74% (estimate =-.744, p = 0.003) and 0.26% (estimate =-.26, p < 0.001), respectively with the COVID-19 pandemic. Conclusion: Further studies are required to investigate what may have contributed to these results. (c) 2024 The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:10
相关论文
共 60 条
  • [1] Adebisi Yusuff Adebayo, 2021, Infect Dis (Auckl), V14, p11786337211033870, DOI 10.1177/11786337211033870
  • [2] Evaluation of Bi-Lateral Co-Infections and Antibiotic Resistance Rates among COVID-19 Patients
    Ahmed, Naveed
    Khan, Madiha
    Saleem, Waqas
    Karobari, Mohmed Isaqali
    Mohamed, Roshan Noor
    Heboyan, Artak
    Rabaan, Ali A.
    Mutair, Abbas Al
    Alhumaid, Saad
    Alsadiq, Salman A.
    Bueid, Ahmed S.
    Santali, Eman Y.
    Alestad, Jeehan H.
    [J]. ANTIBIOTICS-BASEL, 2022, 11 (02):
  • [3] An Assessment of the Impact of Coronavirus Disease (COVID-19) Pandemic on National Antimicrobial Consumption in Jordan
    Al-Azzam, Sayer
    Mhaidat, Nizar Mahmoud
    Banat, Hayaa A.
    Alfaour, Mohammad
    Ahmad, Dana Samih
    Muller, Arno
    Al-Nuseirat, Adi
    Lattyak, Elizabeth A.
    Conway, Barbara R.
    Aldeyab, Mamoon A.
    [J]. ANTIBIOTICS-BASEL, 2021, 10 (06):
  • [4] The Spectrum of Antibiotic Prescribing During COVID-19 Pandemic: A Systematic Literature Review
    Al-Hadidi, Sara H.
    Alhussain, Hashim
    Abdel Hadi, Hamad
    Johar, Alreem
    Yassine, Hadi M.
    Al Thani, Asmaa A.
    Eltai, Nahla O.
    [J]. MICROBIAL DRUG RESISTANCE, 2021, 27 (12) : 1705 - 1725
  • [5] Surveillance of Antibacterial Usage during the COVID-19 Pandemic in England, 2020
    Andrews, Amelia
    Budd, Emma L.
    Hendrick, Aoife
    Ashiru-Oredope, Diane
    Beech, Elizabeth
    Hopkins, Susan
    Gerver, Sarah
    Muller-Pebody, Berit
    [J]. ANTIBIOTICS-BASEL, 2021, 10 (07):
  • [6] [Anonymous], 2022, Antimicrobial resistance surveillance in Europe 2022-2020 data
  • [7] The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective
    Ansari, Shamshul
    Hays, John P.
    Kemp, Andrew
    Okechukwu, Raymond
    Murugaiyan, Jayaseelan
    Ekwanzala, Mutshiene Deogratias
    Alvarez, Maria Josefina Ruiz
    Paul-Satyaseela, Maneesh
    Iwu, Chidozie Declan
    Balleste-Delpierre, Clara
    Septimus, Ed
    Mugisha, Lawrence
    Fadare, Joseph
    Chaudhuri, Susmita
    Chibabhai, Vindana
    Wadanamby, J. M. Rohini W. W.
    Daoud, Ziad
    Xiao, Yonghong
    Parkunan, Thulasiraman
    Khalaf, Yara
    M'Ikanatha, Nkuchia M.
    van Dongen, Maarten B. M.
    [J]. JAC-ANTIMICROBIAL RESISTANCE, 2021, 3 (02):
  • [8] Antibiotic stewardship program in Pakistan: a multicenter qualitative study exploring medical doctors' knowledge, perception and practices
    Atif, Muhammad
    Ihsan, Beenish
    Malik, Iram
    Ahmad, Nafees
    Saleem, Zikria
    Sehar, Azka
    Babar, Zaheer-ud-Din
    [J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [9] Testing indicators to monitor the COVID-19 pandemic
    Beaute, Julien
    Adlhoch, Cornelia
    Bundle, Nick
    Melidou, Angeliki
    Spiteri, Gianfranco
    [J]. LANCET INFECTIOUS DISEASES, 2021, 21 (10) : 1344 - 1345
  • [10] Introducing an antibiotic stewardship program in a humanitarian surgical hospital
    Bhalla, Naina
    Hussein, Nagham
    Atari, Maha
    Fakhri, Rasheed M.
    Lepora, Chiara
    Walsh, Nadia
    Cosgrove, Sara E.
    Murphy, Richard A.
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2016, 44 (11) : 1381 - 1384